Company Filing History:
Years Active: 2015-2024
Title: Innovations by Glenn Liu
Introduction
Glenn Liu is an accomplished inventor based in Waunakee, Wisconsin. He has made significant contributions to the field of medical technology, particularly in the monitoring and evaluation of treatment side effects in cancer patients. With a total of three patents to his name, Liu's work is at the forefront of improving patient care and treatment outcomes.
Latest Patents
One of Liu's latest patents is an "Apparatus for monitoring treatment side effects." This innovative system utilizes physiological imaging techniques to provide a comprehensive assessment of organ health during cancer treatment. It aims to monitor treatment side effects effectively, ensuring that patients receive the best possible care. Another notable patent is the "System and method for evaluation of disease burden." This sensitive method employs molecular and anatomical imaging scans to automatically identify and quantify tumors within specific anatomical zones. By isolating absolute or comparative measures of tumors in pre- and post-scans, this system enhances the ability to track treatment progress, especially when multiple disease lesions are present.
Career Highlights
Throughout his career, Glenn Liu has worked with prominent organizations such as the Wisconsin Alumni Research Foundation and Aiq Global, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Liu has collaborated with notable professionals in his field, including Robert Jeraj and Daniel Huff. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Glenn Liu's contributions to medical technology through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to monitoring treatment side effects and evaluating disease burden are paving the way for advancements in cancer treatment.